Orange Peel Compound Plant Beverage improving nonalcoholic fatty liver disease through anti-inflammatory and antioxidant factors and gut microbiota in rat model

Key Points

• Improvement in nonalcoholic fatty liver disease was observed with dietary intake of the orange peel beverage, indicating its therapeutic potential.
• The study showed a significant decrease in liver inflammation and oxidative stress markers, with a notable 40% reduction observed after treatment.
• Analysis using a rat model demonstrated how the orange peel compound influences gut microbiota composition, impacting overall liver health and inflammation signals.
• Highlighting the potential of using natural dietary products, this finding suggests further exploration for human applications may be beneficial.